Below are the most recent publications written about "Kidney Diseases" by people in Profiles.
-
Tsang YP, Aryeh KS, Wang K, Himmelfarb J, Yeung CK, Kelly EJ. Enhancing therapeutic strategies and drug development for patients with kidney disease. Expert Opin Drug Saf. 2026 Jan; 25(1):23-48.
-
Claudel SE, Verma A. Albuminuria in Cardiovascular, Kidney, and Metabolic Disorders: A State-of-the-Art Review. Circulation. 2025 Mar 11; 151(10):716-732.
-
Ghanta SN, Lessey C, Makwana B, Ganatra S, Dani SS. Obesity and Cardiovascular-Kidney-Metabolic Health: Ethnicity-Based Risk and Clinical Considerations. Cardiol Clin. 2025 Aug; 43(3):383-401.
-
Anand S, O'Neill-Dee M, Sanchorawala V, Verma A. Light-chain (AL) amyloidosis for nephrologists-treatment standard. Nephrol Dial Transplant. 2024 Dec 20; 40(1):34-47.
-
Materne E, Zhou B, DiGiacomo D, Farmer JR, Fuleihan R, Sullivan KE, Cunningham-Rundles C, Ballas ZK, Suez D, Barmettler S. Renal complications in patients with predominantly antibody deficiency in the United States Immune Deficiency Network (USIDNET). J Allergy Clin Immunol. 2024 Jul; 154(1):237-242.e1.
-
Srivastava A, Amodu A, Liu J, Verma A, Mothi SS, Palsson R, Stillman IE, Kestenbaum BR, Waikar SS. The Associations of Urine Albumin-Protein Ratio With Histopathologic Lesions and Clinicopathologic Diagnoses in Individuals With Kidney Disease. Am J Kidney Dis. 2024 04; 83(4):557-560.
-
Zhu K, Mukherjee K, Wei C, Hayek SS, Collins A, Gu C, Corapi K, Altintas MM, Wang Y, Waikar SS, Bianco AC, Koch A, Tacke F, Reiser J, Sever S. The D2D3 form of uPAR acts as an immunotoxin and may cause diabetes and kidney disease. Sci Transl Med. 2023 09 20; 15(714):eabq6492.
-
Verscaj CP, Velez-Bartolomei F, Bodle E, Chan K, Lyons MJ, Thorson W, Tan WH, Rodig N, Graham JM, Peron A, Quintero-Rivera F, Zackai EH, Thomas MA, Stevens CA, Adam MP, Bird LM, Jones MC, Matalon DR. Characterization of the prenatal renal phenotype associated with 17q12, HNF1B, microdeletions. Prenat Diagn. 2024 02; 44(2):237-246.
-
Paudel S, Geetha P, Kyriazis P, Specht A, Hu H, Danziger J. Association of environmental lead toxicity and hematologic outcomes in patients with advanced kidney disease. Nephrol Dial Transplant. 2023 05 04; 38(5):1337-1339.
-
Duong CN, Akinlawon OJ, Gung J, Noel SE, Bigornia S, Flanagan K, Pourafshar S, Lin PH, Davenport CA, Pendergast J, Scialla JJ, Tucker KL. Bioavailability of phosphorus and kidney function in the Jackson Heart Study. Am J Clin Nutr. 2022 08 04; 116(2):541-550.